Rachel Knox, MD, M.B.A.

Dr. Rachel Knox, MD, MBA, is a prominent figure in the field of cannabinoid medicine and serves on the SRAC Medical Subcommittee at the Council for Federal Cannabis Regulation (CFCR). She is recognized as a specialist in cannabinoid medicine and clinical endocannabinology, having received her medical and business degrees from Tufts University after completing her undergraduate studies at Duke University. Dr. Knox has trained in family, integrative, and functional medicine, and has furthered her education in cannabinology and endocannabinology, focusing on the endocannabinoid system's role in health.123

In addition to her clinical practice, Dr. Knox is deeply involved in advocacy and policy reform related to cannabis and health equity. She is the co-founder and president of the Cannabis Health Equity Movement (CHEM) and chairs the Association for Cannabis Health Equity and Medicine (ACHEM). Her work emphasizes addressing health disparities in marginalized communities through education and policy initiatives. Dr. Knox has also held significant roles in various organizations, including serving as the immediate past chair of the Oregon Cannabis Commission and being a member of the Portland Cannabis Policy Oversight Team.123

Dr. Knox's commitment to health equity extends to her efforts in educating communities of color about the therapeutic potential of cannabis and psychedelics, aiming to bridge the health disparity gap. She is a thought leader and public speaker in the cannabis space, advocating for the integration of cannabinoid medicine into mainstream healthcare practices.1234